Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
2.310
-0.160 (-6.48%)
At close: Jun 16, 2026, 4:00 PM EDT
2.350
+0.040 (1.73%)
After-hours: Jun 16, 2026, 7:56 PM EDT
Jaguar Health Employees
Jaguar Health had 47 employees as of December 31, 2025. The number of employees decreased by 2 or -4.08% compared to the previous year.
Employees
47
Change (1Y)
-2
Growth (1Y)
-4.08%
Revenue / Employee
$629,128
Profits / Employee
-$1,066,511
Market Cap
1.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -2 | -4.08% |
| Dec 31, 2024 | 49 | 0 | - |
| Dec 31, 2023 | 49 | -11 | -18.33% |
| Dec 31, 2022 | 60 | 8 | 15.38% |
| Dec 31, 2021 | 52 | 18 | 52.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Ensysce Biosciences | 10 |
| Oragenics | 3 |
| Onconetix | 2 |
JAGX News
- 4 days ago - Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases - Accesswire
- 6 days ago - Jaguar Health Transcript: Emerging Growth Conference 93 - Transcripts
- 8 days ago - Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders - Accesswire
- 18 days ago - Jaguar Health Proxy statement: Proxy filing - Filings
- 19 days ago - Jaguar Health says research in ethnobotanical medicine helps advance crofelemer - TheFly
- 19 days ago - Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders - Accesswire
- 19 days ago - Jaguar Health Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 20 days ago - Jaguar Health regains compliance with Nasdaq Listing Rule - TheFly